Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Nts45 Regulatory News (33JE)

Share Price Information for Barclays Nts45 (33JE)

Share Price is delayed by 15 minutes
Get Live Data
284.95034    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
33JE Live PriceLast checked at - London Stock Exchange

Intraday Barclays Nts45 Share Chart

Shawbrook Group plc Post-Stabilisation Notice

28 Nov 2025 17:14

RNS Number : 5211J
Barclays Bank PLC
28 November 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL. 

28 November 2025

Shawbrook Group plcPost-Stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 30 October 2025, Barclays Capital Securities Limited (Contact: Ben Newmark; Telephone: +44 20 3134 8574) hereby gives notice that the Stabilising Manager named below and its affiliates undertook stabilisation in accordance with the relevant provisions of the Market Abuse Regulation (EU) No 596/2014 of the European Parliament and of the Council (as it forms part of retained EU law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018).

 The securities

Issuer

Shawbrook Group plc

Securities

Ordinary Shares of £0.005 pence each

ISIN

GB00BV9DPV21

Offering Size

94,007,050 Ordinary Shares (excluding the over-allotment option)

Description

Initial Public Offering of Ordinary Shares

Offer price

370 pence per Ordinary Share

Stabilising Manager

Barclays Capital Securities Limited, 1 Churchill Place, London, E14 5HP, United Kingdom

Stabilisation period

From 30 October 2025 to 28 November 2025

Stabilisation last occurred on

24 November 2025

Stabilisation trading venue(s)

London Stock Exchange

Stabilisation transactions

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

Execution Date

Lowest Price

Highest Price

Trading Venue

5 November 2025

370.00

370.00

London Stock Exchange

6 November 2025

370.00

370.00

London Stock Exchange

18 November 2025

370.00

370.00

London Stock Exchange

19 November 2025

370.00

370.00

London Stock Exchange

20 November 2025

369.00

370.00

London Stock Exchange

21 November 2025

366.00

366.00

London Stock Exchange

24 November 2025

366.00

366.00

London Stock Exchange

Barclays Capital Securities Limited, acting as the stabilising manager, has today given notice to exercise the over-allotment option (the "Over-allotment Option") granted by Marlin Bidco Limited in respect of 13,673,547 ordinary shares in Shawbrook at the offer price of 370 pence per share.

Giving effect to the exercise of the Over-allotment Option, the final size of the Offer is approximately £398 million (approximately 108 million ordinary shares), representing approximately 21 per cent. of the ordinary shares in Shawbrook.

 

Important legal information

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

In the United Kingdom, this announcement is being distributed only to, and is directed only at, persons who: (A) (i) are "investment professionals" specified in Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article 49(2)(a) to (d) of the Order (and only where the conditions contained in those Articles have been, or will at the relevant time be, satisfied); and (B) are "qualified investors" within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018 (all such persons together being referred to as "Relevant Persons").

In any member state of the European Economic Area ("EEA") (each, a "Relevant Member State"), this announcement and any offer if made subsequently is, and will be, directed only at persons who are "qualified investors" ("Qualified Investors") within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129).

This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to: (i) in the United Kingdom, Relevant Persons; and (ii) in any member state of the EEA, Qualified Investors, and will be engaged in only with such persons.

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933 as amended (the "Securities Act") and may not be offered or sold in the United States except to "qualified institutional buyers" as defined in, and in reliance on, Rule 144A under the Securities Act or another exemption from, or transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFEEFWAEISEFF
Date   Source Headline
5th Jun 20266:15 pmRNSDirector Declaration
28th May 20266:15 pmRNSPublication of a Supplementary Prospectus
28th Apr 20267:00 amRNSPillar 3 Report Q1 2026
11th Mar 20267:00 amRNSPricing of accelerated placing in Harbour Energy
10th Mar 20265:00 pmRNSLaunch of accelerated placing of shares in Harbour
10th Mar 20265:00 pmRNSLaunch of accelerated placing of shares in Harbour
11th Feb 20264:10 pmRNSAnnual Financial Report on Form 20-F 2025
10th Feb 20267:00 amRNSAnnual Financial Report
6th Feb 20269:00 amRNSDirectorate change
3rd Feb 20264:58 pmRNSFinal Terms
23rd Dec 20253:03 pmRNSPublication of a Supplementary Prospectus
23rd Dec 20253:03 pmRNSPublication of a Supplementary Prospectus
28th Nov 20255:14 pmRNSShawbrook Group plc Post-Stabilisation Notice
24th Nov 20255:27 pmRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Group plc Mid-Stabilisation Notice
6th Nov 20254:32 pmRNSCancellation of Securities - Replacement
5th Nov 20252:03 pmRNSCancellation of XS3100475469
30th Oct 20257:00 amRNSShawbrook Group plc Pre-Stabilisation Notice
22nd Oct 20257:00 amRNSPublication of Q3 2025 Pillar 3 Report
12th Sep 20252:40 pmRNSPublication of Final Terms
27th Aug 202512:29 pmRNSPublication of Final Terms
21st Aug 202511:20 amRNSPublication of Final Terms
1st Aug 20255:13 pmRNSPublication of Final Terms
1st Aug 20251:19 pmRNSPublication of Final Terms
1st Aug 20251:17 pmRNSPublication of Final Terms
31st Jul 20254:00 pmRNSPublication of Base Prospectus Supplement
29th Jul 20257:00 amRNSHalf-year Report
28th Jul 20254:19 pmRNSPublication of Final Terms
28th Jul 202510:41 amRNSPublication of Final Terms
28th Jul 202510:33 amRNSPublication of Final Terms
25th Jul 20253:10 pmRNSPublication of Final Terms
2nd Jul 20255:20 pmRNSPublication of Base Prospectus
1st Jul 20257:00 amRNSPricing of accelerated placing of shares in InPost
30th Jun 20254:56 pmRNSLaunch of accelerated placing of shares in InPost
24th Jun 20253:42 pmRNSPublication of Final Terms
10th Jun 202512:37 pmRNSPublication of Final Terms
10th Jun 202512:36 pmRNSPublication of Final Terms
30th May 20253:48 pmRNSPublication of Final Terms
30th May 20253:39 pmRNSPublication of Final Terms
29th May 20255:19 pmRNSPublication of Final Terms
29th May 20252:33 pmRNSPublication of Final Terms
29th May 20252:29 pmRNSPublication of Final Terms
27th May 20256:14 pmRNSPublication of Final Terms
27th May 20254:40 pmRNSPublication of Final Terms
23rd May 20253:28 pmRNSPublication of Final Terms
20th May 20254:23 pmRNSPublication of Final Terms
20th May 20254:04 pmRNSPublication of Final Terms
15th May 20254:47 pmRNSPublication of Final Terms
15th May 20254:43 pmRNSPublication of Final Terms
15th May 20254:39 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.